Cargando…

PT653. Experience using suvorexant to treat delirium

Detalles Bibliográficos
Autores principales:	Fujiwara, Kodo, Kohata, Shinichi, Sumiyoshi, Hidenori, Kataoka, Tsutomu, Takeshita, Osamu, Omura, Jun, Kuroda, Junko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616985/ http://dx.doi.org/10.1093/ijnp/pyw044.653

Ejemplares similares

PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016)

653. To Treat or Not to Treat Corynebacterium striatum? That is the Question
por: Soriano, Katrina, et al.
Publicado: (2018)

PT666. Check an effeciency About the Suvorexant with Combining Other Sleep Promoting Medicines
por: Akira Iwanami, Toshiaka Tsuneoka, et al.
Publicado: (2016)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
por: Tamura, Kiyoshi, et al.
Publicado: (2018)

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium
por: Nazeer, Sahana, et al.
Publicado: (2023)

Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial
por: Azuma, Kazunari, et al.
Publicado: (2018)

Effect of Suvorexant on Nocturnal Delirium in Elderly Patients with Alzheimer’s Disease: A Case-series Study
por: Hanazawa, Tomoki, et al.
Publicado: (2019)

Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

653. Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose
por: lin, jeffrey, et al.
Publicado: (2020)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Reducing the effect of immortal time bias affects the analysis of prevention of delirium by suvorexant in critically ill patients: A retrospective cohort study
por: Shiotsuka, Junji, et al.
Publicado: (2022)

653. Diagnosis of Burn Sepsis Using the FcMBL ELISA: A Pilot Study in Critically Ill Burn Patients
por: Akers, Kevin S, et al.
Publicado: (2019)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit
por: Azimaraghi, Omid, et al.
Publicado: (2020)

Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021)

Fluorescence Diagnosis in Neurooncology: Retrospective Analysis of 653 Cases
por: Goryaynov, Sergey A., et al.
Publicado: (2019)

Correction to Lancet Neurol 2019; 18: 653–65
Publicado: (2019)

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION
por: Li, Dalin, et al.
Publicado: (2022)

Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
por: McGaughey, Georgia, et al.
Publicado: (2014)

Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience
por: Matsumura, Takuma, et al.
Publicado: (2019)

THU653 Subacute Thyroiditis Following Covid19 Infection
por: Fanous, Ereeny, et al.
Publicado: (2023)

PT715. The regulation of male pup-toward behavior by sexual hormones
por: Ito, Kazuki, et al.
Publicado: (2016)

PT634. Alleviation of neuropathic pain treated with opioid by electroconvulsive therapy
por: Iwata, Ken, et al.
Publicado: (2016)

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
por: Toi, Norikazu, et al.
Publicado: (2018)

Quantification of Suvorexant in Human Urine Using a Validated HPTLC Bioanalytical Method
por: Alqarni, Mohammed H., et al.
Publicado: (2023)

Recent results on semimuonic decays of charm mesons from Fermilab experiment E653
por: Gibaut, D B, et al.
Publicado: (1994)

Health Disparities in Delirium
por: Dicks, Robert, et al.
Publicado: (2021)

Delirium
Publicado: (1904)

Mechanisms of aerobic dechlorination of hexachlorobenzene and pentachlorophenol by Nocardioides sp. PD653
por: Ito, Koji
Publicado: (2021)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

PT635. Opposite associations between the rs3845446 single-nucleotide polymorphism of the CACNA1E gene and postoperative pain-related phenotypes in gastrointestinal surgery versus previously reported orthognathic surgery
por: Amano, Kojiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3i8i5kncri9eqnlq1dgqefgmhq